UMass seed-funding program awards grants to BMP faculty members' UMMS tech development projectsUMass seed-funding program awards grants to two UMMS tech development projects
Two promising research projects at UMass Medical School are getting $25,000 each in seed funding from the UMass Technology Development Fund. One study is focused on developing technology to prevent bedsores. The other seeks to rapidly diagnose a mutated gene that causes amyotrophic lateral sclerosis (ALS). Eight projects across the University of Massachusetts system are receiving funds from the fund, which helps to bring cutting-edge UMass research to market.
Zuoshang Xu, MD, PhD, professor of biochemistry & molecular pharmacology, and Thoru Pederson, PhD, the Vitold Arnett Professor of Cell Biology, and professor of biochemistry & molecular pharmacology, have developed a method to detect a mutated gene that causes a majority of inherited cases of the severe neurodegenerative disease ALS. The researchers are working to adapt the method to inner cheek cell specimens.
More about Dr. Zuoshang Xu:https://profiles.umassmed.edu/display/133183
More about Dr. Thoru Pederson: https://profiles.umassmed.edu/display/132829